Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Davidson

Showing results (201-210 of 285) with videos related to

Pageof 29
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 21, 2020
Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common GoalMasumi Ueda, Renato Martins, Paul C Hendrie, et al.
Breast Cancer Research : BCR|August 8, 2015
The molecular landscape of premenopausal breast cancerSerena Liao, Ryan J Hartmaier, Kandace P McGuire, et al.
The Breast Journal|June 28, 2026
Real-World Practice Patterns in Diagnosis and First-Line Treatment in Metastatic Breast CancerPoorni M Manohar, Veena Shankaran, Nancy E Davidson, et al.
Contemporary Clinical Trials|November 6, 2022
A digital health intervention to improve nutrition and physical activity in breast cancer survivors: Rationale and design of the Cook and Move for Your Life pilot and feasibility randomized controlled trialKatherine Ueland, Sofia Cobos Sanchez, Eileen Rillamas-Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2009
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white womenAni Balmanoukian, Zhe Zhang, Stacie Jeter, et al.
NPJ Breast Cancer|November 16, 2017
A metastasis biomarker (MetaSite <i>Breast</i>™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancerJoseph A Sparano, Robert Gray, Maja H Oktay, et al.
Breast Cancer Research : BCR|October 3, 2015
The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831Edith A Perez, Frederick L Baehner, Steven M Butler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancerEdith A Perez, Vera J Suman, Nancy E Davidson, et al.
Breast Cancer Research and Treatment|February 26, 2011
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancerRoisin M Connolly, Michelle A Rudek, Elizabeth Garrett-Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline updateJames L Khatcheressian, Patricia Hurley, Elissa Bantug, et al.
Pageof 29

Showing results (201-210 of 285) with videos related to

Sort By:
Pageof 29
Journal of the National Comprehensive Cancer Network : JNCCN|March 21, 2020
Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common GoalMasumi Ueda, Renato Martins, Paul C Hendrie, et al.
Breast Cancer Research : BCR|August 8, 2015
The molecular landscape of premenopausal breast cancerSerena Liao, Ryan J Hartmaier, Kandace P McGuire, et al.
The Breast Journal|June 28, 2026
Real-World Practice Patterns in Diagnosis and First-Line Treatment in Metastatic Breast CancerPoorni M Manohar, Veena Shankaran, Nancy E Davidson, et al.
Contemporary Clinical Trials|November 6, 2022
A digital health intervention to improve nutrition and physical activity in breast cancer survivors: Rationale and design of the Cook and Move for Your Life pilot and feasibility randomized controlled trialKatherine Ueland, Sofia Cobos Sanchez, Eileen Rillamas-Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2009
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white womenAni Balmanoukian, Zhe Zhang, Stacie Jeter, et al.
NPJ Breast Cancer|November 16, 2017
A metastasis biomarker (MetaSite <i>Breast</i>™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancerJoseph A Sparano, Robert Gray, Maja H Oktay, et al.
Breast Cancer Research : BCR|October 3, 2015
The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831Edith A Perez, Frederick L Baehner, Steven M Butler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancerEdith A Perez, Vera J Suman, Nancy E Davidson, et al.
Breast Cancer Research and Treatment|February 26, 2011
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancerRoisin M Connolly, Michelle A Rudek, Elizabeth Garrett-Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline updateJames L Khatcheressian, Patricia Hurley, Elissa Bantug, et al.
Pageof 29